An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations

NCT02934698 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Ivacaftor

Sponsor

Medical University of South Carolina

Collaborators

[object Object]